glp 1 doctors GLP-1 medications didn’t suddenly appear out of nowhere. They’ve been studied for years — long before the headlines, celebrity chatter, and overnight “miracle drug” narratives., In Part of this 363. GLP-1 Agonists: Diving into

As obesity therapies become more effective and convenient, the conversation will shift from "Does it work?" to "Who can afford it, and who gets coverage?" The next battleground could be reimbursement rather than efficacy

Abstract Background Chronic kidney disease (CKD) is estimated that by 2040, it will be the 5th highest cause of years of life lost globally due to the aging population and the rising prevalence of age-related diseases such as hypertension and diabetes

Free PEC eBook Get our guide to our PEC supplement

One of the benefits of Noom is that they offer a more affordable option, the Microdose Program

Gut microbiota-derived tryptophan metabolites maintain gut and systemic homeostasis